Posters
« Back
Alignment of chromatograms to facilitate visual comparison of data collected at different points in time or with different instruments
EP23991
Alignment of chromatograms to facilitate visual comparison of data collected at different points in time or with different instruments
Submitted on 25 Apr 2016

Patrik Petersson1, Annika Sjölander1, Melvin R Euerby2,3, Andrey Vazhentsev4 and Karim Kassam4
1Novo Nordisk A/S, Novo Nordisk Park, DK-2760 Måløv, Denmark 2Hichrom Ltd, 1 The Markham Centre, Station Road, Theale, Reading Berkshire, RG7 4PE, England 3Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G40RE 4Advanced Chemistry Development (ACD/Labs), 8 King Street East, Suite 107, Toronto, M5C 1B5, Canada.
Poster Views: 635
View poster »
Poster Abstract
Data collection at different time points or with different instruments, e.g., during the stability studies conducted during the development of pharmaceuticals, will differ slightly due to column or mobile phase batch to batch variation. Also differences between instruments will contribute, e.g. column thermostat design, dwell volume, etc. This will result in small shifts in selectivity, retention, signal intensity and shape/level of the baseline. It thereby becomes difficult to visually spot differences between chromatograms. The current study describes the development and evaluation of an algorithm that address this problem.

[1] ACD/ChromWorkbook 2015 (modified alpha version Feb 2015),Advanced Chemistry Development (ACD/Labs), Toronto, Canada, www.acdlabs.comReport abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


MODEL-AD: Bioinformatics and Data ManagementMODEL-AD: Bioinformatics and Data Management
Bruce Lamb1, Michael Sasner2, Andrew Saykin1, Lara Mangravite3, Gregory Carter2

MODEL-AD: The Disease Modeling Project
M.Sasner1, A. Oblak2, H. Williams1, G. Howell1, B.T. Lamb2 and the MODEL-AD consortium

MODEL-AD: Genetic models of late-onset Alzheimer’s disease
*A. OBLAK1,2, G. CARTER3, G. R. HOWELL3, B. LOGSDON4, L. MANGRAVITE4, K. NHO2, L. OMBERG4, K. D. ONOS3, V. PHILIP3, C. PREUSS3, S. J. SUKOFF RIZZO3, M. SASNER3, L. SHEN1,2, A. J. SAYKIN1,2, P. TERRITO1,2, A. UYAR3, H. WILLIAMS3, B. T. LAMB1,5

Preclinical drug screening in new generation Alzheimer’s disease mouse models: The MODEL-AD Consortium Strategy
P.R. Territo1, S.J. Sukoff Rizzo2, K. Onos2, J.A. Meyer1, J. Peters1, S.C. Persohn1, B.R. McCarthy1, A.A. Riley1, S. Quinney1, D. Jones1, M. Sasner2, G. Howell2, H. Williams2, A.J. Oblak1, B.L. Lamb1 and the MODEL-AD consortium

Generating Unbiased Structural Alternatives for Automated Structure Verification
Sergey Golotvin, Rostislav Pol, Mikhail Elyashberg, Dimitris Argyropoulos and Karim Kassam